Chargement en cours...
Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
There is increasing interest in rituximab (RTX) as an alternative to cyclophosphamide for the treatment of interstitial lung diseases (ILDs) associated with systemic sclerosis (SSc). However, no report has addressed its efficacy in Saudi patients with SSc-ILD. To assess the efficacy of RTX treatment...
Enregistré dans:
| Publié dans: | Ann Thorac Med |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5656950/ https://ncbi.nlm.nih.gov/pubmed/29118864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/atm.ATM_30_17 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|